Abstract
The retinoblastoma protein (pRb) is one of the key cell-cycle regulating proteins and its inactivation leads to neoplastic transformation and carcinogenesis. This protein regulates critical G1-to-S phase transition through interaction with the E2F family of cell-cycle transcription factors repressing transcription of genes required for this cell-cycle check-point transition. Its activity is regulated through network sensing intracellular and extracellular signals which block or permit phosphorylation (inactivation) of the Rb protein. Mechanisms of Rb-dependent cell-cycle control have been widely studied over the past couple of decades. However, recently it was found that pRb also regulates apoptosis through the same interaction with E2F transcription factors and that Rb-E2F complexes play a role in regulating the transcription of genes involved in differentiation and development.
Similar content being viewed by others
Abbreviations
- Cdk:
-
cyclin-dependent kinase
- HDAC:
-
histone deacetylase
- INK4:
-
inhibitor of kinase 4
- pRb:
-
retinoblastoma protein
- TNF:
-
tumour necrosis factor
References
Adnane J, Shao Z and Robbins P D 1995 The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter; J. Biol. Chem. 270 8837–8843
Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A and Harel-Bellan A 2004 A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells; EMBO J. 23 605–615
Borges H L, Hunton I C and Wang J Y J 2007 Reduction of apoptosis in Rb-deficient embryos via Abl knockout; Oncogene 26 3868–3877
Brehm A, Miska E A, McCance D J, Reid J L, Bannister A J and Kouzarides T 1998 Retinoblastoma protein recruits histone deacetylase to repress transcription; Nature (London) 391 597–601
Carreira S, Goodal J, Aksan I, La Rocca S A, Galibert M D, Denat L, Larue L and Goding C R 2005 Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression; Nature (London) 433 764–769
Cavanaugh A H, Hempel W M, Taylor L J, Rogalsky V, Todorov G and Rothblum L I 1995 Activity of RNA polymerase I transcription factor UBF blocked by RB gene product; Nature (London) 374 177–180
Chau B N, Borges H B, Chen T-T, Masselli A, Hunton I C and Wang J Y 2002 Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb; Nat. Cell Biol. 4 757–765
Chau B N and Wang J Y 2003 Coordinated regulation of life and death by Rb; Nat. Rev. Cancer 3 130–138
Clarke A R, Maandag E R, van Roon M, van der Lugt N M, van der Valk M, Hooper M L, Berns A and Riele H 1992 Requirement for a functional Rb-1 gene in murine development; Nature (London) 359 328–330
Deléhouzée S, Yoshikawa T, Sawa C, Sawada J, Ito T, Omori M, Wada T, Yamaguchi Y, Kabe Y and Handa H 2005 GABP, HCF-1 and YY1 are involved in Rb gene expression during myogenesis; Genes to Cells 10 717–731
Dirlam A, Spike B T and MacLeod K F 2007 Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts; Mol. Cell. Biol. 27 8713–8728
Du W and Pogoriler J 2006 Retinoblastoma family genes; Oncogene 25 5190–5200
Dyson N, Howley P M, Munger K and Harlow E 1989 The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product; Science 243 934–937
Ezhevsky S A, Nagahara H, Vocero-Akbani A M, Gius D R, Wei M C and Dowdy S F 1997 Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb; Proc. Natl. Acad. Sci. USA 94 10699–10704
Fattman C L, Delach S M, Dou Q P and Johnson D E 2001 Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide induced apoptosis; Oncogene 20 2918–2926
Felsani A, Mileo A M and Paggi M G 2006 Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins; Oncogene 25 5277–5285
Felsenfeld G 1992 Chromatin as a essential part of transcriptional mechanism; Nature (London) 355 219–224
Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A and Trouche D 1998 The three members of the pocket family share the ability to repress E2F activity through recruitment of a histone deacetylase; Proc. Natl. Acad. Sci. USA 95 10493–10498
Garnovskaya M N, Mukhin Y V, Vlasova T M, Grewal J S, Ullian M E, Tholanikunnel B G and Raymond J R 2004 Mitogen-induced rapid phosphorylation of serine 795 of the retinoblastoma gene product in vascular smooth muscle cells involves ERK activation; J. Biol. Chem. 279 24899–24905
Giacinti C and Giordano A 2006 RB and cell cycle progression; Oncogene 25 5220–5227
Goodrich D W, Wang N P, Qian Y-W, Lee E Y -H P and Lee W-H 1991 The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle; Cell 67 293–302
Grunstein M 1997 Histone acetylation in chromatin structure and transcription; Nature (London) 389 349–352
Guo Z, Yikang S, Yoshida H, Mak T W and Zacksenhaus E 2001 Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis; Cancer Res. 61 8395–8400
Hamel P A, Gill R M, Phillips R A and Gallie B L 1992 Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene; Mol. Cell. Biol. 12 3431–3438
Harbour J W, Luo R X, Dei Santi A, Postigo A A and Dean D C 1999 Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb function as a cell move through G1; Cell 98 856–869
Hasig C A, Fleischer T C, Billin A N, Schreiber S L and Ayer D E 1997 Histone deacetylase activity is required for full transcriptional repression by mSin3A; Cell 89 341–347
He S, Cook B L, Deverman B E, Weihe U, Zhang F, Prachand V, Zheng J and Weintraub S J 2000 E2F is required to prevent inappropriate S-phase entry of mammalian cellsM; Mol. Cell. Biol. 20 363–371
Helin K, Harlow E and Fattaey A 1993 Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein; Mol. Cell. Biol. 13 6501–6508
Helt A-M and Galloway D A 2003 Mechanisms by which tumor virus oncoproteins target the Rb family of pocket proteins; Carcinogenesis 24 159–169
Hiebert S W, Chellapan S P, Horowitz J M and Nevins J R 1992 The interaction of Rb with E2F coincides with an inhibition of the transcriptional activity of E2F; Genes Dev. 6 177–185
Hinds P W, Mittnacht S, Dulic V, Arnold A, Reed S I and Weinberg R A 1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins; Cell 70 993–1006
Hirai H, Roussel M F, Kato J Y, Ashmun R A and Sherr C J 1995 Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6; Mol. Cell. Biol. 15 2672–2681
Horowitz J M, Park S H, Bogenmann E, Cheng J C, Yandell D W, Kaye F J, Minna J D, Dryja T P and Weinberg R A 1990 Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells; Proc. Natl. Acad. Sci. USA 87 2775–2779
Iavarone A, King E R, Dai X M, Leone G, Stanley E R and Lasorella A 2004 Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages; Nature (London) 432 1040–1045
Khatib Z A, Matsushime H, Valentine M, Shapiro D N, Sherr C J and Look A T 1993 Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas; Cancer Res. 53 5535–5541
Knudsen E S and Wang J Y J 1996 Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites; J. Biol. Chem. 261 8313–8320
Lin B T and Wang J Y 1992 Cell cycle regulation of retinoblastoma protein phosphorylation; Ciba Found. Symp. 170 227–241
Liu X, Clements A, Zhao K and Marmorstein R 2006 Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor; J. Biol. Chem. 281 578–586
Liu X and Marmorstein R 2007 Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor; Genes Dev. 21 2711–2716
Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff A A, Jansen-Durr P, Strauss M and Bartek J 1994 DNA Tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell’s requirement for cyclin D1 function in G1; J. Cell Biol. 125 625–638
Ludlow J W, DeCaprio J A, Huang C-M, Lee W-H, Paucha E and Livingston D M 1989 SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family; Cell 56 57–65
Lundberg A S and Weinberg R A 1998 Functional inactivation of the retinoblastoma protein requires sequential modification of retinoblastoma protein by at least two distinct cyclin-Cdk complexes; Mol. Cell. Biol. 18 735–761
Luo R X, Postigo A A and Dean D C 1998 Rb interacts with histone deacetylase to repress transcription; Cell 92 463–473
Macleod K F, Hu Y and Jacks T 1996 Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system; EMBO J. 15 6178–6188
Masselli A and Wang J Y J 2006 Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli; Oncogene 25 1290–1298
Miskolczi P, Lendvai A, Horváth G V, Pettkó-Szandtner A, Dudits D 2007 Conserved functions of retinoblastoma proteins: from purple retina to green plant cells; Plant Sci. 172 671–683
Mittnacht S and Bosshof C 2000 Vital cyclins; Rev. Med. Virol. 10 175–184
Morisaki H, Fujimoto A, Ando A, Nagata Y, Ikeda K and Nakanishi M 1997 Cell cycle-dependent phosphorylation of p27 cyclindependent kinase (Cdk) inhibitor by cyclin E/Cdk2; Biochem. Biophys. Res. Commun. 240 386–390
Moreland J L, Gramada A, Buzko O V, Zhang Q and Bourne P E 2005 The molecular biology toolkit (MBT): a modular platform for developing molecular visualization applications; BMC Bioinformatics 6 21
Nguyen D X, Baglia L A, Huang S-M, Baker C M and McCance D J 2004 Acetylation regulates the differentiation-specific functions of the retinoblastoma protein; EMBO J. 23 1609–1618
Parra M A and Wyrick J J 2007 Regulation of gene transcription by the histone H2A N-terminal domain; Mol. Cell. Biol. 27 7641–7648
Pazin M J and Kadonaga J T 1997 What’s up and down with histone deacetylation and transcription?; Cell 89 325–328
Perez-Roger I, Solomon D L, Sewing A and Land H 1997 Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27 (Kip1) binding to newly formed complexes; Oncogene 14 2373–2381
Qian Y W, Wang Y C, Hollingsworth R E Jr, Jones D, Ling N and Lee E Y 1993 A retinoblastoma-binding protein related to a negative regulator of Ras in yeast; Nature (London) 364 648–652
Reissmann P T, Koga H, Figlin R A, Holmes E C and Slamon D J 1999 Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer; J. Cancer Res. Clin. Oncol. 125 61–70
Rekhtman N, Choe K S, Matushansky I, Murray S, Stopka T and Skoultchi A I 2003 PU.1 and pRb interact and cooperate to repress GATA-1 and block erythroid differentiation; Mol. Cell. Biol. 23 7460–7474
Rubin E, Mittnach S, Villa-Moruzzi E and Ludlow J W 2001 Site-specific and temporally regulated retinoblastoma protein dephosphorylation by protein phosphatase type I; Oncogene 20 3776–3785
Sage C, Huang M, Karimi K, Gutierrez G, Vollrath M A, Zhang D S, Garcia Anoveros J, Hinds P W, Corvin J T, Corey D P and Chen Z-Y 2005 Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein; Science 307 1114–1118
Sankaran V G, Orkin S H and Walkley C R 2008 Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis; Genes Dev. 22 463–475
Sellers W R, Rodgers J W and Kaelin W Jr 1995 A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites; Proc. Natl. Acad. Sci. USA 92 11544–11548
Shapiro G I, Park J E, Edwards C D, Mao L, Merlo A, Sidransky D, Ewen M E and Rollins B J 1995 Multiple mechanisms of p16INK4a in non-small cell lung cancer cell lines; Cancer Res. 55 6200–6209
Sherr C J 1996 Cancer cell cycles; Science 274 1672–1677
Sherr C J and McCormic F 2002 The RB and p53 pathways in cancer; Cancer Cell 2 103–112
Siddiqui H, Solomon D A, Gunawardena R W, Wang Y and Knudsen E S 2003 Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition; Mol. Cell. Biol. 23 7719–7731
Siddiqui H, Fox S R, Gunawardena R W, Knudsen E S 2007 Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics; J. Cell. Physiol. 211 131–137
Simpson M T W, MacLaurin J G, Xu D, Ferguson K L, Vanderluit J L, Davoli M A, Roy S, Nicholson D W, Robertson G S, Park D S and Slack R S 2001 Caspase 3 deficiency rescues peripheral nervous system defect in retinoblastoma nullizygous mice; J. Neurosci. 21 7089–7098
Tan X, Martin S J, Green D R and Wang J Y 1997 Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death; J. Biol. Chem. 272 9613–9616
Taunton J, Hassig C A and Schreiber S L A 1996 Mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p; Science 272 408–411
Tsai K, Hu Y, Macleod K, Crowley D, Yamasaki L and Jacks T 1998 Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos; Mol. Cell 2 293–304
Xiao B, Spencer J, Clements A, Ali-Khan N, Mittnacht S, Broceño C, Burghammer M, Perrakis A, Marmorstein R and Gamblin S J 2003 Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation; Proc. Natl. Acad. Sci. USA 100 2363–2368
Xing E P, Yang G-Y, Wang L-D, Shi S T and Yang C S 1999 Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer; Clin. Cancer Res. 5 1231–1240
Weinberg R A 1995 The retinoblastoma protein and cell cycle control; Cell 81 323–330
Weintraub S J, Prater C A and Dean D C 1992 Retinoblastoma protein switches the E2F site from positive to negative element; Nature (London) 358 259–261
Weintraub S J, Chow K N B, Luo R X, Zhang S H, He S and Dean D C 1995 Mechanism of active transcriptional repression by the retinoblastoma protein; Nature (London) 375 812–815
White R J, Trouche J, Martin K, Jackson S P and Kouzarides T 1996 Repression of RNA polymerase III transcription by the retinoblastoma protein; Nature (London) 382 88–90
Whyte P, Bukowich K J, Horowitz J M, Friend S H, Raybuck M, Weinberg R A and Harlow E 1988 Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product; Nature (London) 334 124–129
Wolffe A P and Pruss D 1996 Targeting chromatin disruption: transcription regulators that acetylase histones; Cell 84 817–819
Wong S and Weber J D 2007 Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1; Biochem. J. 407 451–460
Zarkowska T and Mittnacht S 1997 Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases; J. Biol. Chem. 272 12738–12746
Zhang Y, Xiong Y and Yarbrough W G 1998 ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways; Cell 92 725–734
Zhang H S, Postigo A A and Dean D C 1999 Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ and contact inhibition; Cell 97 53–61
Zhu J W, DeRyckere D, Li F X, Wan Y Y and DeGregori J 1999 A role of E2F-1 in the induction of ARF, p53 and apoptosis during thymic negative selection; Cell Growth Differ. 10 829–838
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poznic, M. Retinoblastoma protein: a central processing unit. J Biosci 34, 305–312 (2009). https://doi.org/10.1007/s12038-009-0034-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-009-0034-2